Author: Bill Snyder
Harvard’s Seidman to speak at VU
Mar. 7, 2013—Jonathan Seidman, Ph.D., who has made pivotal contributions to understanding the genetic basis of cardiomyopathy and other heart diseases, will deliver the next Flexner Discovery Lecture on Thursday, March 14.
Gene ‘dose’ may be key to autism
Mar. 4, 2013—Individuals with overexpression of the gene MECP2 have core features of autism spectrum disorder.
Potent genetic risk factor for breast cancer identified
Feb. 28, 2013—Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.
Institute of Chemical Biology to celebrate 10th anniversary
Feb. 28, 2013—Top chemists from around the country will be on hand March 12 to celebrate the 10th anniversary of the Vanderbilt Institute of Chemical Biology (VICB), a brave experiment that helped jumpstart the University’s robust drug discovery initiative.
Discovery Lecture explores brain’s sensitivity to insulin
Feb. 28, 2013—Diabetes has a big impact on the brain.
Series of events explore brain disorders, neuroscience research
Feb. 21, 2013—“Brain Blast,” a half-day of free, hands-on activities for children and adults will be held from 9 a.m. to 1 p.m., Saturday, March 2, at Vanderbilt Health One Hundred Oaks.
Cure in sight for kissing bug’s bite
Feb. 15, 2013—It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model.
Vaccination still key defense as flu season continues
Feb. 14, 2013—As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard.
Harvard’s Kahn set for Discovery Lecture
Feb. 14, 2013—C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.
VU, GlaxoSmithKline team to develop novel treatments for severe obesity
Feb. 11, 2013—Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.
Humble yeast helps predict how genes are regulated
Feb. 7, 2013—Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years.
For people with ASD, adulthood no easy transition
Feb. 7, 2013—One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood.